Allmed Historical Income Statement

002950 Stock

8.99 0.11 1.21%

Historical analysis of Allmed Medical income statement accounts such as Interest Income of 2.5 M, Interest Expense of 24.1 M or Selling General Administrative of 151.3 M can show how well Allmed Medical Products performed in making a profits. Evaluating Allmed Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Allmed Medical's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Allmed Medical Products latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Allmed Medical Products is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Allmed Medical Products. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Allmed Income Statement Analysis

Allmed Medical Products Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Allmed Medical shareholders. The income statement also shows Allmed investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Allmed Medical Income Statement Chart

At present, Allmed Medical's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Interest Income is expected to grow to about 2.5 M, whereas Net Interest Income is forecasted to decline to (32.9 M).

Tax Provision Selling General Administrative Total Revenue Gross Profit

Tax Provision

The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.

Total Revenue

Total revenue comprises all receipts Allmed Medical Products generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Allmed Medical Products minus its cost of goods sold. It is profit before Allmed Medical operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Most accounts from Allmed Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Allmed Medical Products current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Allmed Medical Products. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2021	2022	2023	2024 (projected)
Gross Profit	881.5M	1.4B	768.6M	994.9M
Total Revenue	2.9B	4.2B	2.8B	2.9B

Gross Profit Total Revenue

Allmed Medical income statement Correlations

	Tax Provision	Net Interest Income	Interest Income	Selling General Administrative	Total Revenue	Gross Profit	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Net Income	Other Operating Expenses	Ebitda	Reconciled Depreciation	Income Tax Expense	Minority Interest
Tax Provision		0.1	0.92	0.07	0.77	0.89	0.94	0.88	0.94	0.83	0.68	0.65	0.9	0.88	-0.06	0.97	0.46	0.99	-0.07
Net Interest Income	0.1		0.06	-0.9	-0.33	-0.16	0.01	0.35	0.35	-0.2	-0.41	-0.44	0.33	0.35	-0.51	0.05	-0.48	0.11	0.44
Interest Income	0.92	0.06		0.19	0.87	0.91	0.89	0.79	0.78	0.95	0.82	0.8	0.81	0.79	0.03	0.93	0.61	0.91	-0.41
Selling General Administrative	0.07	-0.9	0.19		0.52	0.35	0.18	-0.15	-0.24	0.42	0.59	0.62	-0.13	-0.15	0.66	0.08	0.53	0.02	-0.68
Total Revenue	0.77	-0.33	0.87	0.52		0.96	0.87	0.55	0.55	0.98	0.99	0.98	0.58	0.56	0.21	0.81	0.82	0.75	-0.59
Gross Profit	0.89	-0.16	0.91	0.35	0.96		0.97	0.73	0.73	0.94	0.89	0.88	0.76	0.74	0.07	0.88	0.65	0.86	-0.36
Operating Income	0.94	0.01	0.89	0.18	0.87	0.97		0.84	0.83	0.87	0.77	0.75	0.86	0.84	-0.07	0.89	0.48	0.89	-0.17
Net Income From Continuing Ops	0.88	0.35	0.79	-0.15	0.55	0.73	0.84		0.87	0.62	0.43	0.39	1.0	1.0	-0.23	0.78	0.11	0.82	0.13
Ebit	0.94	0.35	0.78	-0.24	0.55	0.73	0.83	0.87		0.62	0.43	0.39	0.88	0.87	-0.22	0.9	0.26	0.95	0.21
Research Development	0.83	-0.2	0.95	0.42	0.98	0.94	0.87	0.62	0.62		0.96	0.95	0.65	0.63	0.17	0.87	0.79	0.82	-0.58
Cost Of Revenue	0.68	-0.41	0.82	0.59	0.99	0.89	0.77	0.43	0.43	0.96		1.0	0.46	0.43	0.28	0.74	0.88	0.66	-0.69
Total Operating Expenses	0.65	-0.44	0.8	0.62	0.98	0.88	0.75	0.39	0.39	0.95	1.0		0.42	0.4	0.31	0.72	0.89	0.64	-0.71
Income Before Tax	0.9	0.33	0.81	-0.13	0.58	0.76	0.86	1.0	0.88	0.65	0.46	0.42		1.0	-0.22	0.81	0.15	0.84	0.11
Net Income	0.88	0.35	0.79	-0.15	0.56	0.74	0.84	1.0	0.87	0.63	0.43	0.4	1.0		-0.23	0.78	0.11	0.82	0.12
Other Operating Expenses	-0.06	-0.51	0.03	0.66	0.21	0.07	-0.07	-0.23	-0.22	0.17	0.28	0.31	-0.22	-0.23		-0.01	0.39	-0.05	-0.49
Ebitda	0.97	0.05	0.93	0.08	0.81	0.88	0.89	0.78	0.9	0.87	0.74	0.72	0.81	0.78	-0.01		0.62	0.99	-0.16
Reconciled Depreciation	0.46	-0.48	0.61	0.53	0.82	0.65	0.48	0.11	0.26	0.79	0.88	0.89	0.15	0.11	0.39	0.62		0.51	-0.67
Income Tax Expense	0.99	0.11	0.91	0.02	0.75	0.86	0.89	0.82	0.95	0.82	0.66	0.64	0.84	0.82	-0.05	0.99	0.51		-0.05
Minority Interest	-0.07	0.44	-0.41	-0.68	-0.59	-0.36	-0.17	0.13	0.21	-0.58	-0.69	-0.71	0.11	0.12	-0.49	-0.16	-0.67	-0.05

Click cells to compare fundamentals

Allmed Medical Account Relationship Matchups

Allmed Medical income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Tax Provision	70.0M	178.2M	73.5M	80.3M	64.8M	84.1M
Net Interest Income	(41.5M)	(12.8M)	(19.1M)	(38.6M)	(31.3M)	(32.9M)
Interest Income	1.2M	6.5M	4.2M	3.1M	1.9M	2.5M
Interest Expense	37.4M	17.7M	17.2M	35.5M	31.9M	24.1M
Selling General Administrative	192.2M	90.1M	140.7M	182.4M	125.0M	151.3M
Total Revenue	2.4B	3.8B	2.9B	4.2B	2.8B	2.9B
Gross Profit	797.1M	1.6B	881.5M	1.4B	768.6M	994.9M
Operating Income	415.5M	1.2B	458.3M	877.6M	325.3M	579.6M
Net Income From Continuing Ops	324.2M	1.2B	432.0M	404.6M	104.2M	99.0M
Ebit	285.8M	398.7M	1.2B	387.6M	445.8M	537.5M
Research Development	59.7M	118.1M	94.6M	107.7M	77.4M	81.3M
Cost Of Revenue	1.6B	2.2B	2.0B	2.8B	2.0B	1.9B
Total Operating Expenses	1.9B	2.6B	2.5B	3.3B	2.4B	2.4B
Income Before Tax	394.2M	1.3B	505.5M	484.9M	169.0M	160.6M
Net Income	325.8M	1.2B	431.2M	406.8M	110.4M	104.9M
Other Operating Expenses	3.0M	37.9M	4.8M	19.1M	22.0M	16.9M
Ebitda	552.9M	1.5B	669.9M	713.6M	820.6M	779.2M
Reconciled Depreciation	121.4M	142.2M	147.2M	193.2M	227.4M	161.4M
Net Income Applicable To Common Shares	227.8M	325.8M	1.2B	431.2M	495.9M	522.7M
Income Tax Expense	50.1M	70.0M	178.2M	73.5M	84.6M	92.6M
Minority Interest	7.5M	12.4M	(745.6K)	2.1M	6.2M	5.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Other Information on Investing in Allmed Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Allmed Historical Income Statement

About Allmed Income Statement Analysis

Allmed Medical Income Statement Chart

Tax Provision

Total Revenue

Gross Profit

Allmed Medical income statement Correlations

Allmed Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Allmed Medical income statement Accounts

Also Currently Popular

Other Information on Investing in Allmed Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Income Before Tax	+ 1.0	Net Income From Continuing Ops
Net Income	+ 1.0	Net Income From Continuing Ops
Total Operating Expenses	+ 1.0	Cost Of Revenue
Net Income	+ 1.0	Income Before Tax
Income Tax Expense	+ 0.99	Tax Provision
Cost Of Revenue	+ 0.99	Total Revenue

Selling General Administrative	- 0.9	Net Interest Income
Minority Interest	- 0.71	Total Operating Expenses
Minority Interest	- 0.69	Cost Of Revenue
Minority Interest	- 0.68	Selling General Administrative
Minority Interest	- 0.67	Reconciled Depreciation
Minority Interest	- 0.59	Total Revenue